‘2 Strong’ system in entecavir market, led by Dong-A and Bukwang

In the market of entecavir(product name: Baraclude), one of the last year’s largest issues in the patent expiration field, Dong-A ST and Bukwang Pharm have formed a 2-stong competition.

For the 3^rd position, Hanmi Pharm and Samil Pharm have started to get prepared as increasing their products’ prescriptions.

According to the analysis result of major entecavir products’ outpatient prescriptio...